Release Date: 20/04/11 14:03 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 193.77KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%